Skip to content

De Grave Vreugde Therapeutics

Active Private limited companyfounded 2025active for 1 yearVenneborglaan 78, 2100 AntwerpKBO/BCE: BE 1019.638.561

Lifetime

1 annual account with figures
peak of -€10,092 in 2025
-€10,092 
lowest -€10,632 in 2025
-€10,632 
peak of -€7,632 in 2025
-€7,632 
€22,749 
Board1 name since 2025
1 director
Documentsfilings and deeds
04-08-20264 days late
2025micro format
Loss of €10,632Incorporation 07-021 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Equity

-€7,632
2025

Debts exceed assets in financial year 2025.

Debts

€22,749 150% of the balance sheet
2025 accounts filed 4 days after the deadlineTurnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,324 companies had the same profile as De Grave Vreugde Therapeutics has now. Each dot stands for 4 companies, two years later.

90.2%
were still trading
5.7%
stopped another way
4.2%
went bankrupt
  • Micro
  • under 2 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,324 companies, not a prediction for De Grave Vreugde Therapeutics. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 1,000 sharesdeed of 07-02-2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1019638561
Incorporation Founding capital of €3,000, 1,000 shares · Founded by · appointed as statutory director · published on 07-02-2025 · Gazette deed
First establishment Venneborglaan 78, Antwerp
All 4 events

Official details

Source: KBO
Status
Active since 05-02-2025Normal situation
Activity
Psychology servicesNACE 869311 activity on the establishment unitFrom the articles, 31 activities
Establishment unit
2.369.993.3772100 Antwerp, since 05-02-2025
Financial year end
31 December
Peppol
Reachable since 19-12-2025
Company details

Annual accounts 2025

€15,117
Filing
Filed on 04-08-2026
Financials

Insights on De Grave Vreugde Therapeutics

The 2025 annual accounts show negative equity of -€7,632 and a net result of -€10,632. The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about De Grave Vreugde Therapeutics

What is the company number of De Grave Vreugde Therapeutics?
The company number of De Grave Vreugde Therapeutics is 1019.638.561. The VAT number is the same number with BE in front: BE 1019.638.561.
Where is De Grave Vreugde Therapeutics based?
The registered office is at Venneborglaan 78, 2100 Antwerp.Company details
What does De Grave Vreugde Therapeutics do?
According to the KBO register, the main activity of the establishment unit is psychology services (NACE 86931).
What is the legal form of De Grave Vreugde Therapeutics?
De Grave Vreugde Therapeutics is a private limited company (BV).
When was De Grave Vreugde Therapeutics founded?
De Grave Vreugde Therapeutics was founded on 05-02-2025.
Is De Grave Vreugde Therapeutics still active?
Yes, De Grave Vreugde Therapeutics is an active enterprise in the KBO register.
What is the turnover of De Grave Vreugde Therapeutics?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
Is De Grave Vreugde Therapeutics profitable?
In financial year 2025, De Grave Vreugde Therapeutics made a loss of €10,632.
Where can I find the annual accounts of De Grave Vreugde Therapeutics?
De Grave Vreugde Therapeutics filed 1 annual account with the National Bank of Belgium, for financial year 2025.
When are the next annual accounts of De Grave Vreugde Therapeutics due?
De Grave Vreugde Therapeutics must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.